APO-PANTO
40MG TBL ENT 56
| SÚKL code | 0122625 |
|---|---|
| Name of the product | APO-PANTO |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | APO-PANTO |
| Supplement | 40MG TBL ENT 56 |
| Strenght | 40MG |
| Pharmaceutical form | Gastro-resistant tablet |
| Package | 56 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLUM NATRICUM SESQUIHYDRICUM) |
| ATC group | A02BC02 |
| ATC group name | PANTOPRAZOL |
Marketing authorisation information
| Registration Number | 09/ 094/08-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 10. 2020 |
| MA Holder | Apotex Europe B.V., Leiden |
| MA Holder country | NIZOZEMSKO |
| Actual MA holder | Aurovitas, spol. s r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz